Page last updated: 2024-09-03

lysyl-aspartyl-glutamyl-leucine and transforming growth factor alpha

lysyl-aspartyl-glutamyl-leucine has been researched along with transforming growth factor alpha in 1 studies

Compound Research Comparison

Studies
(lysyl-aspartyl-glutamyl-leucine)
Trials
(lysyl-aspartyl-glutamyl-leucine)
Recent Studies (post-2010)
(lysyl-aspartyl-glutamyl-leucine)
Studies
(transforming growth factor alpha)
Trials
(transforming growth factor alpha)
Recent Studies (post-2010) (transforming growth factor alpha)
1210224,30144623

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beckett, MA; Cha, A; Heimann, R; Kufe, DW; Margulies, I; Nodzenski, E; Pastan, I; Seetharam, S; Weichselbaum, RR1

Other Studies

1 other study(ies) available for lysyl-aspartyl-glutamyl-leucine and transforming growth factor alpha

ArticleYear
Modulation of apoptotic response of a radiation-resistant human carcinoma by Pseudomonas exotoxin-chimeric protein.
    Cancer research, 1998, Aug-01, Volume: 58, Issue:15

    Topics: ADP Ribose Transferases; Animals; Apoptosis; Bacterial Toxins; Binding Sites; Carcinoma, Squamous Cell; Ceramides; Combined Modality Therapy; Drug Synergism; ErbB Receptors; Exotoxins; Female; Head and Neck Neoplasms; Humans; Mice; Mice, Nude; Mutation; Neoplasm Transplantation; Oligopeptides; Protein Sorting Signals; Pseudomonas aeruginosa Exotoxin A; Radiation Tolerance; Recombinant Fusion Proteins; Transforming Growth Factor alpha; Transplantation, Heterologous; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Virulence Factors

1998